Cargando…

Changes in anti-viral effectiveness of interferon after dose reduction in chronic hepatitis c patients: a case control study

BACKGROUND: High dose interferon induction treatment of hepatitis C viral infection blocks viral production over 95%. Since dose reduction is often performed due to clinical considerations, the effect of dose reduction on hepatitis C virus kinetics was studied. METHODS: A new model that allowed long...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bekkering, Frank C, Neumann, Avidan U, Brouwer, Johannes T, Levi-Drummer, Rachel S, Schalm, Solko W
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2001
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC64636/ https://www.ncbi.nlm.nih.gov/pubmed/11801193 http://dx.doi.org/10.1186/1471-230X-1-14

Ejemplares similares

Retreatment of hepatitis C non-responsive to Interferon. A placebo controlled randomized trial of Ribavirin monotherapy versus combination therapy with Ribavirin and Interferon in 121 patients in the Benelux [ISRCTN53821378]
por: Veldt, Bart J, et al.
Publicado: (2003)

Long-term effects of treatment and response in patients with chronic hepatitis C on quality of life. An international, multicenter, randomized, controlled study
por: Bezemer, Geert, et al.
Publicado: (2012)

The cost-effectiveness of treating chronic hepatitis B patients in a median endemic and middle income country
por: Toy, Mehlika, et al.
Publicado: (2012)

Considering Personalized Interferon Beta Therapy for COVID-19
por: Dorgham, Karim, et al.
Publicado: (2021)

Age- and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic review
por: Toy, Mehlika, et al.
Publicado: (2011)

Novel Pegylated Interferon for the Treatment of Chronic Viral Hepatitis
por: Huang, Yi-Wen, et al.
Publicado: (2022)

Generic and disease-specific health related quality of life in non-cirrhotic, cirrhotic and transplanted liver patients: a cross-sectional study
por: van der Plas, Simone M, et al.
Publicado: (2003)

Interferon-Based Anti-Viral Therapy for Hepatitis C Virus Infection after Renal Transplantation: An Updated Meta-Analysis
por: Wei, Fang, et al.
Publicado: (2014)

Comparison of the effects of low dose interferon and high dose interferon on reduction of the number and size of plaques in patients with Multiple Sclerosis: A historical cohort
por: Khomand, Payam, et al.
Publicado: (2017)

Interferons and viral infections
por: Higgins, P. G.
Publicado: (1984)

A Novel Unsupervised Method to Identify Genes Important in the Anti-viral Response: Application to Interferon/Ribavirin in Hepatitis C Patients
por: Brodsky, Leonid I., et al.
Publicado: (2007)

The Inaugural Australian Centre for Hepatitis Virology Public Panel Discussion on Viral Hepatitis Research—Lessons in Scientific Community Outreach
por: Tu, Thomas, et al.
Publicado: (2021)

El interferon en el tratamiento de la hepatitis crónica activa viral:
por: Aguirre Sánchez, Rosa Albina
Publicado: (1994)

Role of viral and host factors in interferon based therapy of hepatitis C virus infection
por: Imran, Muhammad, et al.
Publicado: (2013)

Adaptation of hepatitis C virus to interferon lambda polymorphism across multiple viral genotypes
por: Chaturvedi, Nimisha, et al.
Publicado: (2019)

Interferon and Ocular Viral Disease
por: Galin, Miles A., et al.
Publicado: (1970)

Interferon, Mx, and viral countermeasures
por: Haller, Otto, et al.
Publicado: (2007)

Viral suppression of the interferon system
por: Weber, Friedemann, et al.
Publicado: (2007)

Whence Interferon? Variety in the Production of Interferon in Response to Viral Infection
por: Levy, David E.
Publicado: (2002)

Update on Viral Hepatitis
por: Khan, R U, et al.
Publicado: (1997)

El interferon en el tratamiento de la hepatitis crónica activa viral. : revisión bibliográfica /
por: Aguirre Sánchez, Rosa Albina
Publicado: (1994)

Innate and adaptive anti-viral immune responses in MS patients treated with interferon-beta
por: Petersen, Thor, et al.
Publicado: (2011)

Hepatitis C: viral and host factors associated with non-response to pegylated interferon plus ribavirin
por: Asselah, Tarik, et al.
Publicado: (2010)

Interferon lambda 4 impairs hepatitis C viral antigen presentation and attenuates T cell responses
por: Chen, Qian, et al.
Publicado: (2021)

Interferon alpha antagonizes the anti-hepatoma activity of the oncolytic virus M1 by stimulating anti-viral immunity
por: Ying, Liu, et al.
Publicado: (2017)

Interferons: Signaling, antiviral and viral evasion
por: Bonjardim, Cláudio A., et al.
Publicado: (2009)

Interferons and Their Use in Persistent Viral Infections
por: Chevaliez, Stéphane, et al.
Publicado: (2009)

Viral Infections and Interferons in the Development of Obesity
por: Tian, Yun, et al.
Publicado: (2019)

Viral recognition and the antiviral interferon response
por: Dalskov, Louise, et al.
Publicado: (2023)

Adherence to Anti-Viral Treatment for Chronic Hepatitis B
por: Abu-Freha, Naim, et al.
Publicado: (2020)

Harm reduction and viral hepatitis C in European prisons: a cross-sectional survey of 25 countries
por: Bielen, Rob, et al.
Publicado: (2018)

Effect of hepatic iron concentration and viral factors in chronic hepatitis C-infected patients with thalassemia major, treated with interferon and ribavirin
por: Jafroodi, Maryam, et al.
Publicado: (2011)

Structure-based glycoengineering of interferon lambda 4 enhances its productivity and anti-viral potency
por: Chung, Jae-Hee, et al.
Publicado: (2020)

Disruption of type I interferon signaling causes sexually dimorphic dysregulation of anti-viral cytokines
por: Darzianiazizi, Maedeh, et al.
Publicado: (2021)

Hydrogen peroxide attenuates rhinovirus-induced anti-viral interferon secretion in sinonasal epithelial cells
por: Lee, Sang Hag, et al.
Publicado: (2023)

Viral Hepatitis in the Air Force
por: Corker, Frank T.
Publicado: (1976)

Challenges to the development of vaccines to hepatitis C virus that elicit neutralizing antibodies
por: Drummer, Heidi E.
Publicado: (2014)

Serum hepatitis B viral DNA in HBsAg-positive hepatocellular carcinoma treated with interferon or adriamycin.
por: Lin, H. J., et al.
Publicado: (1986)

Novel type I interferon IL-28A suppresses hepatitis C viral RNA replication
por: Zhu, Haizhen, et al.
Publicado: (2005)

Hepatitis C Viral Kinetics as a Determinant of Stopping Pegylated Interferon and Ribavirin in Genotype 1 Infection
por: Kim, Do Young
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_f8afu0sibs77ed7j5puq9lonfr